Abstract:Objective To study dendritic cells(DC)precursors that were mobilized into the pe- ripheral blood by injection of macrophage inflammation protein-1α(MIP-1α)and the anti-tumor effects induced by MIP-1αmobilized DC vaccine expressing tumor antigen in vivo.Methods 615 mice were in- jected with MIP-1αvia the tail vein.B220~-CD11c~+cells were sorted from the peripheral blood mononu- clear cells(MNCs)by FACS.The quantitive change of B220~-CD11c~+cells were compared among MNCs.Freshly isolated B220~-CD11c~+cells and B220~-CD11c~+cells cultured with mouse granulocyte- macrophage colony-stimulating factor(mGM-CSF),interleukin 4(IL-4),and mouse tumor necrosis factor-α(mTNF-α)were analyzed by phenotype analysis,and mixed lymphocyte reaction(MLR).For adenovi- ral(Ad)-mediated gene transduetion,cultured B220~-CD11c~+cells were incubated with Ad-melanoma antigen gene-3.B220~-CD11c~+cells pulsed mouse forestomach carcinoma cells(MFC)tumor lysate was used as control.To establish the solid tumor model,groups of 615 mice were injected with MFC cells sub- cutaneously in the abodminal wall.DC vaccines were immunized after the challenge of MFC cells,then the tumor size and the survival of mice which could detect the anti-tumor effects of DC vaccines were ob- served.Results B220~-CD11c~+cells were increased in the circulation 8 h after MIP-1αinjection, then gradually reached a peak level 48 h after injection,accounting for(13.68±0.95)% among MNCs. Freshly isolated B220~-CD11c~+cells did not show the characters of mature DC,while cultured B220~- CD11c~+cells were phenotyically identical to typical DC and gained the capacity to stimulate allogeneie T cells.These MIP-1αmobilized DCs were transduced with Ad-MAGE-3,which were prepared for DC vac- cines expressing tumor antigen.Five days after the challenge of MFC cells,mice were subsequently injected with DC vaccines.The.tumor size in the experimental group was much smaller than that in the control groups 27 days after the challenge.Kaplan-Meier survival curves revealed that the survival of the mice in the experimental group was much longer than that in the control groups(P<0.01).Conclusion B220~- CD11c~+DC precursors were rapidly accumulated in the peripheral blood after injection of MIP-1αin mice,which could further differentiate into mature DCs.These MIP-1αmobilized DCs,when transduced with MAGE-3 gene,could generate therapeutic anti-tumor effects on MFC cells loading mice in vivo.The efficiency of anti-tumor immunity induced by MIP-1αmobilized DCs expressing tumor antigen were much more potent than MIP-1αmobilized DCs pulsed MFC cells tumor lysate.

THE EFFECTOR FUNCTIONS OF MACROPHAGES TRANSFECTED WITH INTERFERON-GAMMA GENE MEDIATED BY RECOMBINANT ADENOVIRUS

Augmented Cytotoxicity and Antigen Presenting Ability of Macrophages by Transfection with the M-CSF Or/and IFN-γ Gene

Therapeutic Effect of MIP-1alpha-recruited Dendritic Cells on Preestablished Solid and Metastatic Tumors.

Effects of gamma-interferon gene-modified hepatocytes on murine implanted liver carcinoma

The effect of IFNγ gene modified dendritic cells on T cell proliferation and eradication of tumor cells

Enhancement of Mouse Immune Response by Recombinant Adenovirus Co-Expressing VP1-2A of Foot-and-mouth Disease Virus and Porcine IFN-α

Immunotherapy of Melanoma Metastasis by Adoptive Transfer of M-CSF Or/and IFN-γ Gene Modified Macrophages Pulsed with Tumor Extracts

Experimental Gene Therapy Mediated by Macrophage Inflammatory Protein-1Α for Murine Liver Cancer

The Enhance of Mice Immune Response by Porcine IFN- α on Foot and Mouth Disease Recombinant Vaccine

Anti-gastric carcinoma efficacy of gene modified dendritic cell vaccine recruited by macrophage inflammation protein-1

Genetically engineered macrophages expressing IFN-γ restore alveolar immune function in scid mice

Use of Interferon Γ Gene Modified Dendritic Cells in Immunotherapy for Hepatic Cancer

Immunotherapy of Tumors with Recombinant Adenovirus Encoding Macrophage Inflammatory Protein 3β Induces Tumor-Specific Immune Response in Immunocompetent Tumor-Bearing Mice

Dynamic Distribution and Expression in Vivo of the Human Interferon Gamma Gene Delivered by Adenoviral Vector.

Producing genetically engineered macrophages with enhanced immunity via microinjection

Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected …

Coadministration of gene adjuvant MIP-1α and Flt3l to enhance the immunological effect of DNA vaccine to HPV16E7

Antitumour Activity of Cationic‐liposome‐conjugated Adenovirus Containing the CCL19 [chemokine (C‐C Motif) Ligand 19] Gene

Engineered tumor-infiltrating macrophages as gene delivery vehicles for interferon-α activates immunity and inhibits breast cancer progression

Inhibition of Tumor Angiogenesis by Interferon-Γ by Suppression of Tumor-Associated Macrophage Differentiation.

Effects of recombinant murine interlukin-12 and GM-CSF gene adenovirus vectors on B16 melanoma